Clinical Trial Update: Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery [NA]

View source ↗

Summary

The Wake Forest University Health Sciences trial NCT02566421, evaluating genomic sequencing to guide treatment for metastatic, recurrent, or unresectable cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Non-small Cell Lung Cancer
• Stage Iiia Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer
• Unresectable Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Metastatic Neoplasm, Recurrent Neoplasm | NA | Status: TERMINATED